ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the deadliest malignancies worldwide, with late detection, ineffective treatment and poor overall survival. Immunotherapy, including immune checkpoint inhibitor (ICI) therapy, holds great potential for treatment of HCC. Although some patients respond well to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xinyao, Li, Dan, Zhu, Hua, Yu, Tao, Xiong, Xiaoxing, Xu, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428557/
https://www.ncbi.nlm.nih.gov/pubmed/37587505
http://dx.doi.org/10.1186/s12920-023-01624-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428557/
https://www.ncbi.nlm.nih.gov/pubmed/37587505
http://dx.doi.org/10.1186/s12920-023-01624-6

Ejemplares similares